News & Perspective

Oct 19, 2017

Oct 19, 2017
Ferret

Study details pandemic potential of latest H7N9 flu strains

In a sample from a patient who died, researchers saw signs that the H7N9 virus had started to mutate to a form resistant to Tamiflu.

May 23, 2017

May 23, 2017
Federal budget

White House budget proposal spells steep cuts for public health

Though deep cuts aren't likely to be enacted, health groups and experts aired strong concerns.

Jan 07, 2016

Jan 07, 2016
Mutated virus

NSABB launches new phase of GOF research debate

Some topics: weighing risks and benefits, ethical issues, and global involvement.

Jul 11, 2014

Jul 11, 2014
BSL-4 lab worker

More problems shutter CDC labs, prompt review

In addition to recent problems with anthrax and smallpox, high-path avian flu has now entered the mix.

Jul 03, 2014

Jul 03, 2014
Biohazard container

Controversy simmers over GOF flu research in Wisconsin

UW calls a recent UK newspaper story biased and largely wrong.

Aug 14, 2013

Aug 14, 2013
H5N1 color electron micro

Study: Technique adds 'kill switch' to modified flu viruses

A new molecular strategy could diffuse some of the controversy over lab-modified flu viruses.

Jul 09, 2013

Jul 09, 2013
Roosting chickens

H7N9 prompts fresh look at H7 pandemic potential

Experts say some properties of H7 viruses may lend themselves to human adaptation.

Jul 06, 2012

Jul 06, 2012

FLU NEWS SCAN: Resistant H1N1, H5N1 in Indonesia

Antiviral-resistant H1N1 virus in Australia didn't spread farAn oseltamivir-resistant 2009 H1N1 virus that spread in one Australian community in 2011 apparently did not escape to a nearby large city, according to a report published in Eurosurveillance yesterday. Researchers previously reported the community spread of a resistant 2009 H1N1 virus in the Newcastle, Australia, area from June through August of 2011, the report notes.

Pages

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»